Monroe joins forces with world-class partner MSK to prepare future surgical technologists. By President's Office May 08, 2026 This fall, the first cohort of students will begin an exciting new chapter as part of a groundbreaking Surgical Technology apprenticeship program created through a partnership between the University, Memorial Sloan Kettering Cancer Center (MSK), and CareerWise. For Monroe, the collaboration represents more than a new academic offering - it is an opportunity to partner with one of the world's most respected healthcare institutions to help prepare the next generation of surgical technologists. Together, the three organizations are creating a debt-free pathway into a vital healthcare profession, combining college coursework, paid clinical experience, mentorship, and direct connections to the workforce. The inaugural cohort, which will start their studies in the fall semester, will have the opportunity to earn an Associate of Applied Science degree in Surgical Technology at Monroe while gaining hands-on experience in MSK operating rooms. Through the program, MSK will cover tuition, fees, and books, allowing students to graduate debt-free while building the skills and confidence needed to succeed in one of healthcare's most demanding environments. The partnership brings together the strengths of three organizations committed to student success: MSK's world-renowned clinical excellence, CareerWise's innovative apprenticeship model, and Monroe's long-standing commitment to workforce-focused education. Together, they have created a seamless pathway that supports students from recruitment through career placement while helping address growing workforce needs in healthcare. Monroe's Surgical Technology program, housed within the University's School of Allied Health Professions that is led by Dr. Sandy Adler, is designed to prepare students for certification and immediate entry into the workforce. "Our Surgical Technology program is intentionally designed to align with employer expectations and national certification standards," said Daphne Warrington, Program Director of Surgical Technology at Monroe University. "Graduates are prepared not only to sit for certification, but to step confidently into the operating room on day one. Partnering with Memorial Sloan Kettering ensures apprentices are receiving world-class clinical experience alongside a rigorous academic foundation that meets the highest professional standards." University leaders say the partnership reflects a shared commitment to excellence, workforce development, and student success. For Monroe, there is particular pride in collaborating with an institution as globally respected as MSK to help educate healthcare professionals who will play a vital role in patient care. "We are incredibly proud to partner with Memorial Sloan Kettering, a world-class leader in cancer care," said Pamela Lieberman, Senior Vice President, Corporate and Community Outreach. "To help educate and prepare the next generation of surgical technologists who will serve at that level - supporting complex procedures and helping save lives every single day - is both an honor and a responsibility we take very seriously. This partnership reflects the confidence MSK has in Monroe's academic quality and our ability to deliver exceptional outcomes for students and employers alike." Before classes begin, apprentices will participate in campus visits, assessments, financial aid completion, and orientation activities designed to help them transition smoothly into college life. Throughout the program, they will receive personalized support from Monroe faculty, advisors, and leadership. Dr. Militza Gonzales, Monroe's Executive Director of Corporate Partnerships and Advising, emphasized the University's high-touch student support model. "Our approach is simple: we are here whenever our students need us," she said. "Cohort students receive personalized guidance, direct access to leadership, and continuous encouragement. That level of connection helps them persist, thrive, and reach their goals." As healthcare systems nationwide continue to face shortages in specialized clinical roles, programs like this provide meaningful solutions - creating opportunities for students while helping healthcare organizations build the skilled workforce they need. Lieberman added that the partnership's strength lies in shared purpose and sustained engagement. "Successful collaborations are built on trust, accountability, and a deep commitment to student success," she said. "This partnership reflects our shared investment in creating meaningful, debt-free pathways into essential healthcare careers." As Monroe prepares to welcome the first cohort this fall, the University is proud to join MSK and CareerWise in creating new opportunities for students while strengthening the healthcare workforce. The partnership demonstrates how education and industry can work together to expand access to opportunity, support student success, and build the next generation of healthcare professionals.

Integrative breast cancer treatment: combining conventional and holistic approaches. A breast cancer diagnosis is one of the most frightening experiences a person can face. In the days and weeks following a diagnosis, patients are confronted with an overwhelming volume of medical information, treatment decisions, and emotional weight. Conventional oncology offers powerful tools; surgery, chemotherapy, radiation, hormone therapy, and targeted biologics that have dramatically improved survival rates over the past several decades. But increasingly, patients and physicians alike are recognizing that the best outcomes emerge not from conventional treatment in isolation, but from integrative approaches that address the whole person; body, mind, and life alongside the tumor itself. At The Center for Advanced Medicine under the guidance of Dr. Jonathan Stegall, integrative breast cancer treatment is offered as a scientifically grounded, personally tailored approach that works in concert with conventional care to optimize outcomes and quality of life. What is integrative breast cancer treatment? Integrative oncology is not alternative medicine, it does not replace conventional cancer treatment, and it does not involve rejecting evidence-based therapies in favor of unproven remedies. Instead, it combines the proven power of conventional oncology with evidence-based complementary therapies that support the patient's overall health, reduce treatment side effects, enhance the immune system's contribution to cancer control, and address the psychological and lifestyle dimensions of cancer care. The integrative oncology model recognizes that cancer is not simply a tumor to be destroyed, it's a systemic disease that develops within a biological environment (the patient's body) and is influenced by factors including immune function, inflammation, hormonal balance, nutritional status, metabolic health, stress physiology, and lifestyle behaviors. Addressing these factors alongside tumor-directed treatment provides a more comprehensive strategy. The Society for Integrative Oncology and leading academic cancer centers, including Memorial Sloan Kettering, MD Anderson, and the Mayo Clinic, have all developed integrative oncology programs, reflecting the growing mainstream acceptance of this approach. Evidence-Based integrative therapies for breast cancer. Nutritional Optimization Diet is one of the most significant modifiable factors in cancer prognosis and treatment tolerance. Research has identified specific dietary patterns associated with improved outcomes in breast cancer: Anti-inflammatory, plant-rich diets: Diets rich in vegetables, fruits, legumes, whole grains, and healthy fats (particularly omega-3 fatty acids) reduce systemic inflammation, an important driver of cancer progression and treatment resistance. The Mediterranean diet pattern has been studied extensively and is associated with improved cancer outcomes. Sugar and insulin management: Many breast cancers particularly those driven by IGF-1 and insulin signaling, may be promoted by elevated blood sugar and insulin. Reducing dietary glycemic load may help create a metabolic environment less hospitable to cancer growth. Cruciferous vegetables and indole-3-carbinol: Compounds in broccoli, cauliflower, kale, and other cruciferous vegetables have demonstrated anti-cancer properties in laboratory and epidemiological research, including modulation of estrogen metabolism in hormone-receptor-positive breast cancer. Soy: Contrary to earlier concerns, current evidence suggests moderate consumption of whole soy foods is safe and may be beneficial for breast cancer patients, including those with hormone receptor-positive disease. Dr. Stegall provides individualized nutritional guidance based on each patient's tumor characteristics, current treatment, and overall health status. Targeted Supplementation Certain evidence-based supplements may support the body during cancer treatment when used under appropriate medical supervision: Vitamin D: Low vitamin D levels are associated with increased breast cancer risk and worse outcomes. Maintaining optimal vitamin D levels during and after treatment is supported by growing evidence. Omega-3 fatty acids: Anti-inflammatory omega-3s from fish oil have been shown to reduce chemotherapy-induced inflammation and may enhance the efficacy of certain chemotherapy agents. Melatonin: Beyond its sleep-regulating function, melatonin has demonstrated anti-tumor properties in laboratory research and may reduce the toxicity of certain cancer treatments while enhancing their effectiveness. Medicinal mushrooms: Compounds extracted from Reishi, Turkey Tail, and other medicinal mushrooms (particularly beta-glucans) have demonstrated immune-modulating properties that may support immune surveillance of cancer cells. Critical note: Not all supplements are safe during breast cancer treatment. Some including certain antioxidants may interfere with chemotherapy or radiation. Supplement use should always be disclosed to the oncology team and guided by a physician with integrative oncology training, as Dr. Stegall provides. Exercise and Physical Activity Perhaps no integrative intervention has stronger evidence for breast cancer outcomes than exercise. Multiple studies have demonstrated that regular physical activity: * Reduces the risk of breast cancer recurrence by 30% to 50% in survivors * Reduces treatment-related fatigue (one of the most debilitating side effects of chemotherapy and radiation) * Improves mood, anxiety, and depression during and after treatment * Supports immune function * Helps maintain healthy body weight (obesity is associated with worse breast cancer outcomes) Exercise recommendations are individualized based on treatment phase, physical capacity, and any treatment complications. Both aerobic exercise and strength training contribute meaningful benefits. Mind-Body Practices The psychological dimension of breast cancer treatment is profound and often inadequately addressed. Stress, anxiety, depression, and fear of recurrence are nearly universal experiences and they have measurable physiological effects through pathways including the hypothalamic-pituitary-adrenal axis, the autonomic nervous system, and inflammatory cytokine pathways. Evidence-based mind-body practices that benefit breast cancer patients include: Mindfulness-Based Stress Reduction (MBSR): A structured program combining meditation, yoga, and mindfulness that has been shown in clinical trials to reduce anxiety, depression, fatigue, and pain in cancer patients. Yoga: Gentle yoga practices reduce fatigue, improve mood, enhance sleep, and support immune function during and after treatment. Acupuncture: One of the best-studied complementary therapies in oncology, acupuncture has demonstrated effectiveness for chemotherapy-induced nausea and vomiting, hot flashes from hormone therapy, pain, anxiety, and fatigue. Guided imagery and relaxation: Techniques that activate the parasympathetic nervous system, reducing the physiological burden of chronic stress on cancer biology. Immune System Support The immune system plays a central role in cancer surveillance and control. Conventional cancer treatments particularly chemotherapy, can significantly suppress immune function, creating periods of vulnerability. Integrative strategies that support immune resilience include: * Adequate sleep (7-9 hours per night; sleep deprivation significantly impairs immune function) * Stress management (chronic stress suppresses natural killer cell activity, a key immune defense against cancer) * Exercise (moderate exercise enhances immune surveillance) * Targeted supplementation under physician guidance Metabolic Approaches Dr. Stegall's integrative approach includes attention to the metabolic environment in which cancer develops and persists. Metabolic health; insulin sensitivity, inflammatory markers, metabolic syndrome influences cancer biology. Strategies that improve metabolic health (dietary modification, exercise, weight management, sleep optimization) may create conditions less favorable for cancer progression and recurrence. The personalized plan at The Center for Advanced Medicine. Every patient's integrative oncology plan at The Center for Advanced Medicine is as individual as their diagnosis and their life. Dr. Jonathan Stegall reviews each patient's complete medical picture including tumor biology, conventional treatment plan, current health status, lifestyle, and personal goals, and develops a personalized integrative protocol that complements and enhances their conventional care. This approach requires deep expertise in both conventional oncology science and the evidence base for complementary therapies. Dr. Stegall brings this specialized knowledge to every patient relationship, providing care that is both scientifically rigorous and genuinely holistic. Starting the conversation. If you or a loved one has been diagnosed with breast cancer and you're interested in exploring integrative approaches that complement your conventional treatment plan, contact The Center for Advanced Medicine to schedule a consultation with Dr. Jonathan Stegall. Comprehensive cancer care is about more than killing cells it's about supporting the whole person through one of life's most challenging experiences.